Moleculin Biotech Raises $8.3M from Warrants, Issues New 5-Year Warrants
Moleculin Biotech holders exercised 2,122,652 warrants at $3.90 per share, generating $8.3 million in gross proceeds. The company will issue unregistered warrants for up to 6,367,956 shares at $3.90 (or lower VWAP) exercisable over five years pending shareholder approval.
1. Warrant Exercise Details
Moleculin Biotech entered agreements for immediate exercise of 2,122,652 outstanding warrants at $3.90 per share, resulting in approximately $8.3 million in gross proceeds before fees. The shares issuable upon exercise are covered by effective registration statements.
2. Terms of New Warrants
In consideration for the cash exercise, the company will issue unregistered warrants exercisable for up to 6,367,956 shares at an exercise price equal to $3.90 or the lowest VWAP over the next five trading days. These new warrants will become exercisable upon shareholder approval and carry a five-year term from the approval date.
3. Use of Proceeds and Closing
The transaction is expected to close on or about February 20, 2026, subject to customary closing conditions. Net proceeds are intended for working capital and general corporate purposes.